Fate Therapeutics (FATE) News Today $1.14 +0.01 (+0.44%) As of 03:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FATE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Rating of "Hold" from BrokeragesJuly 16 at 2:19 AM | marketbeat.comCould This Hawaii Community Be the Next Lahaina? Some Residents Fear a Similar Wildfire FateJuly 12, 2025 | msn.comFate Therapeutics (NASDAQ:FATE) Shares Pass Below Two Hundred Day Moving Average - Here's What HappenedJuly 12, 2025 | marketbeat.comSmall Caps, Big Potential: Regenerative Medicine Stocks Positioned for Growth (ADIA, FATE, MESO, CRSP)July 9, 2025 | theglobeandmail.comQ2 Earnings Estimate for FATE Issued By HC WainwrightJuly 6, 2025 | americanbankingnews.comResearch Analysts Offer Predictions for FATE Q2 EarningsJuly 4, 2025 | marketbeat.comRick Atkinson's 'The Fate of the Day' traces the middle years of the American RevolutionJuly 3, 2025 | yahoo.comFate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)July 3, 2025 | globenewswire.comFate Therapeutics (NASDAQ:FATE) Downgraded to "Sell" Rating by Wall Street ZenJune 28, 2025 | marketbeat.comTMNT: Splintered Fate - Official Xbox Launch TrailerJune 26, 2025 | msn.comFate Therapeutics (NASDAQ:FATE) Stock Price Crosses Below Two Hundred Day Moving Average - Should You Sell?June 20, 2025 | marketbeat.comFate Therapeutics’ SWOT analysis: promising data boosts stock outlookJune 15, 2025 | investing.comFate Therapeutics, Inc.: Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission ...June 13, 2025 | finanznachrichten.deFate Therapeutics price target lowered to $2.20 by BofA on SLE dataJune 13, 2025 | investing.comFate Therapeutics Reports Promising Clinical Data for FT819 in Treating Severe Lupus Nephritis at EULAR 2025June 13, 2025 | nasdaq.comFate Therapeutics (NASDAQ:FATE) Receives "Hold" Rating from Needham & Company LLCJune 12, 2025 | marketbeat.comFate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 CongressJune 11, 2025 | globenewswire.comBank of America Corp DE Sells 550,066 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE)June 11, 2025 | marketbeat.comAnalysts Set Expectations for FATE FY2026 EarningsJune 10, 2025 | marketbeat.comAt Fate’s End, new game from Spiritfarer developers, revealedJune 9, 2025 | msn.comFate Therapeutics appoints new board memberJune 1, 2025 | investing.comFate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of DirectorsMay 30, 2025 | globenewswire.comFate Therapeutics, Inc. (FATE) Highlights Next-Gen iPSC Therapies for Autoimmune DiseasesMay 28, 2025 | insidermonkey.comFate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 CongressMay 28, 2025 | globenewswire.comFate Therapeutics, Inc. (NASDAQ:FATE) Given Consensus Rating of "Hold" by AnalystsMay 28, 2025 | marketbeat.comFate Therapeutics, Inc. (NASDAQ:FATE) Stock Holdings Trimmed by Woodline Partners LPMay 27, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Decreases Position in Fate Therapeutics, Inc. (NASDAQ:FATE)May 22, 2025 | marketbeat.comVestal Point Capital LP Increases Stock Position in Fate Therapeutics, Inc. (NASDAQ:FATE)May 21, 2025 | marketbeat.comFate Therapeutics, Inc. (NASDAQ:FATE) Holdings Raised by Tang Capital Management LLCMay 20, 2025 | marketbeat.comSphera Funds Management LTD. Purchases Shares of 397,177 Fate Therapeutics, Inc. (NASDAQ:FATE)May 18, 2025 | marketbeat.comNeedham Remains a Hold on Fate Therapeutics (FATE)May 16, 2025 | theglobeandmail.comBarclays Reaffirms Their Buy Rating on Fate Therapeutics (FATE)May 16, 2025 | theglobeandmail.comFate Therapeutics (FATE) Receives a Hold from WedbushMay 16, 2025 | theglobeandmail.comFate Therapeutics (NASDAQ:FATE) Receives Hold Rating from Needham & Company LLCMay 16, 2025 | marketbeat.comFate Therapeutics First Quarter 2025 Earnings: Beats ExpectationsMay 15, 2025 | finance.yahoo.comFate Therapeutics, Inc. (NASDAQ:FATE) Shares Purchased by Dimensional Fund Advisors LPMay 15, 2025 | marketbeat.comIntegral Health Asset Management LLC Lowers Holdings in Fate Therapeutics, Inc. (NASDAQ:FATE)May 14, 2025 | marketbeat.comFate Therapeutics Reports First Quarter 2025 Financial Results and Business UpdatesMay 13, 2025 | globenewswire.comFate Therapeutics: Suffering The Fate Of A Depressed Cell Therapy SectorMay 9, 2025 | seekingalpha.comBaker BROS. Advisors LP Grows Position in Fate Therapeutics, Inc. (NASDAQ:FATE)May 6, 2025 | marketbeat.comFate Therapeutics, Inc. (NASDAQ:FATE) Given Average Rating of "Hold" by BrokeragesMay 4, 2025 | marketbeat.comFate Therapeutics (FATE) Expected to Announce Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comMarshall Wace LLP Makes New Investment in Fate Therapeutics, Inc. (NASDAQ:FATE)May 3, 2025 | marketbeat.comFate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)May 2, 2025 | globenewswire.comFate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual MeetingApril 29, 2025 | globenewswire.comRecent uptick might appease Fate Therapeutics, Inc. (NASDAQ:FATE) institutional owners after losing 66% over the past yearApril 27, 2025 | finance.yahoo.com249,800 Shares in Fate Therapeutics, Inc. (NASDAQ:FATE) Acquired by XTX Topco LtdApril 24, 2025 | marketbeat.comWalleye Capital LLC Has $1.79 Million Position in Fate Therapeutics, Inc. (NASDAQ:FATE)April 22, 2025 | marketbeat.comCerity Partners LLC Grows Holdings in Fate Therapeutics, Inc. (NASDAQ:FATE)April 20, 2025 | marketbeat.comFate Therapeutics receives RMAT designation from FDA for FT819April 14, 2025 | markets.businessinsider.com Get Fate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FATE and its competitors with MarketBeat's FREE daily newsletter. Email Address FATE Media Mentions By Week FATE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FATE News Sentiment▼0.440.97▲Average Medical News Sentiment FATE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FATE Articles This Week▼43▲FATE Articles Average Week Get Fate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FATE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies aTyr Pharma News Siga Technologies News Tourmaline Bio News Cullinan Therapeutics News MBX Biosciences News Rezolute News Kamada News Terns Pharmaceuticals News REGENXBIO News Savara News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FATE) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FATE Stock Alerts